T1	Participants 254 289	patients with respiratory allergies
T2	Participants 45 64	respiratory allergy
T3	Participants 556 612	patients with allergic rhinoconjunctivitis and/or asthma
T4	Participants 641 653	Ten subjects
T5	Participants 710 730	Forty-three subjects
T6	Participants 1250 1258	controls
T7	Participants 1354 1389	patients with respiratory allergies
